Akebia Therapeutics Announces Second Quarter 2018 Financial Results
Go back to Akebia Therapeutics Announces Second Quarter 2018 Financial Results| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 1.09 +0.02 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.07 | 52 Week High | $13.20 | |||
| Open | $1.08 | 52 Week Low | $7.00 | |||
| Day High | $1.14 | P/E | N/A | |||
| Day Low | $1.07 | EPS | $0.00 | |||
| Volume | 5,080,363 | |||||
| Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) | Delayed: 3.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.36 | 52 Week High | $7.80 | |||
| Open | $438.10 | 52 Week Low | $2.80 | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.36 | EPS | $-0.45 | |||
| Volume | 1,132,646 | |||||
